Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00399646 · ClinicalTrials.gov registry record · Phase 2
Evaluation of the Metricath Gemini System, a Device Intended to Make Arterial Measurements and Perform Angioplasty Dilations.
A Phase 2 study, sponsored by Shockwave Medical.
- Completed
- Registry status
- Phase 2
- Development phase
- 145
- Enrollment target
NCT00399646 is a Phase 2 study that has completed, run by Shockwave Medical. The registered enrollment target is 145 participants.
The verdict
NCT00399646, a Phase 2 study, has completed, sponsored by Shockwave Medical.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 145 participants
- Enrollment target
Study Summary
The purpose of the Metricath Gemini System is to pre-dilate the target treatment area, take arterial lumen measurements in a native section of artery or within the deployed stent and perform further dilation of the deployed stent if required. In this manner, the Metricath Gemini System can assist the Interventionalist by providing arterial measurements prior to stenting, performing pre-stenting angioplasty, taking within stent measurements to help determine if the stent is fully deployed, and by performing post-stenting dilations to further dilate the stent if required.
Interventions
- DEVICE Metricath Gemini System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 145 participants |
| Start Date | 2005-11 |
| Est. Completion | 2009-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00399646
The ClinicalTrials.gov registry entry for NCT00399646 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 145 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Shockwave Medical, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Metricath Gemini System is the first listed.
NCT00399646 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00399646 about?
NCT00399646 is a clinical study titled "Evaluation of the Metricath Gemini System, a Device Intended to Make Arterial Measurements and Perform Angioplasty Dilations.". The purpose of the Metricath Gemini System is to pre-dilate the target treatment area, take arterial lumen measurements in a native section of artery or within the deployed stent and perform further dilation of the deployed stent if required. In this manner, the Metricath Gemini System can assist th...
What is the current status of trial NCT00399646?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 145 participants. The study started on 2005-11. Estimated completion is 2009-03.
What interventions are being tested in trial NCT00399646?
The interventions under investigation include: Metricath Gemini System (DEVICE).
Who is sponsoring clinical trial NCT00399646?
This trial is sponsored by Shockwave Medical, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.